ALS: A bucket of genes, environment, metabolism and unknown ingredients.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Progress in neurobiology

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pneurobio.2016.05.004PMID 27236050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.

  2019cited by this paper
• 新しい疾患概念 Globular glial tauopathies(GGT)の画像所見―背景病理との対応

  2017cited by this paper
• C9orf72 is required for proper macrophage and microglial function in mice

  2016cited by this paper
• Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women.

  2016cited by this paper
• NEK1 mutations in familial amyotrophic lateral sclerosis.

  2016cited by this paper
• Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations

  2016cited by this paper
• Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study

  2016cited by this paper
• Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis

  2016cited by this paper
• Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD

  2016cited by this paper
• TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion

  2016cited by this paper
• Amyotrophic lateral sclerosis among cross-country skiers in Sweden

  2016cited by this paper
• Assessing the role of TUBA4A gene in frontotemporal degeneration.

  2016cited by this paper
• C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice

  2016cited by this paper
• Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation.

  2016cited by this paper
• Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers

  2016cited by this paper
• Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis

  2016cited by this paper
• The C9orf72 repeat expansion disrupts nucleocytoplasmic transport

  2015cited by this paper
• "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.

  2015cited by this paper
• Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia

  2015influential reference
• Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.

  2015cited by this paper
• Modulation of SOD1 Subcellular Localization by Transfection with Wild- or Mutant-type SOD1 in Primary Neuron and Astrocyte Cultures from ALS Mice

  2015cited by this paper
• Risk factors for amyotrophic lateral sclerosis

  2015cited by this paper
• Nuclear accumulation of mRNAs underlies G4C2‐repeat‐induced translational repression in a cellular model of C9orf72 ALS

  2015cited by this paper
• Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.

  2015cited by this paper
• Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration

  2015cited by this paper
• C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits

  2015cited by this paper
• Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis.

  2015cited by this paper
• TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations

  2015cited by this paper
• GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport

  2015cited by this paper
• Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43

  2015cited by this paper
• Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin.

  2015cited by this paper
• Deletion of the Rab GAP Tbc1d1 modifies glucose, lipid, and energy homeostasis in mice.

  2015cited by this paper
• Neuroprotective Effect of Bexarotene in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

  2015cited by this paper
• C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits

  2015cited by this paper
• The John Walton Muscular Dystrophy Research Centre in the University of Newcastle and the BMAA Theory of Motor Neuron Disease

  2015cited by this paper
• Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing

  2015cited by this paper
• Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis

  2015cited by this paper
• Job-related formaldehyde exposure and ALS mortality in the USA

  2015cited by this paper
• Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis

  2015cited by this paper
• Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity.

  2015cited by this paper
• Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1.

  2015cited by this paper
• Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis.

  2015cited by this paper
• Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways

  2015cited by this paper
• Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: A new focus of ALS associated with Parkinsonism

  2015cited by this paper
• Early detection of structural abnormalities and cytoplasmic accumulation of TDP-43 in tissue-engineered skins derived from ALS patients

  2015influential reference
• Association between diabetes and amyotrophic lateral sclerosis in Sweden

  2015cited by this paper
• A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis

  2015cited by this paper
• Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy

  2015cited by this paper
• Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis.

  2015cited by this paper
• PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43.

  2015cited by this paper
• A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice.

  2015cited by this paper
• Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

  2015influential reference
• Frequent hepatic steatosis in amyotrophic lateral sclerosis: Implication for systemic involvement

  2015cited by this paper
• An acetylation switch controls TDP-43 function and aggregation propensity

  2015cited by this paper
• An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies

  2015cited by this paper
• C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.

  2015cited by this paper
• Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS.

  2015cited by this paper
• TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD

  2015cited by this paper
• The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients

  2015cited by this paper
• Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis.

  2015cited by this paper
• Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS

  2015cited by this paper
• C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration

  2014cited by this paper
• Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

  2014cited by this paper
• Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells

  2014cited by this paper
• Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review

  2014cited by this paper
• ALS2 mutations

  2014cited by this paper
• Neuregulin‐1 is concentrated in the postsynaptic subsurface cistern of C‐bouton inputs to α‐motoneurons and altered during motoneuron diseases

  2014cited by this paper
• Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan

  2014cited by this paper
• C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins

  2014cited by this paper
• Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases

  2014cited by this paper
• TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.

  2014cited by this paper
• Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset

  2014cited by this paper
• Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model

  2014cited by this paper
• Compensatory Motor Neuron Response to Chromatolysis in the Murine hSOD1G93A Model of Amyotrophic Lateral Sclerosis

  2014cited by this paper
• Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001–2012 survey results

  2014cited by this paper
• Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.

  2014cited by this paper
• Triathletes are over-represented in a population of patients with ALS

  2014cited by this paper
• Accumulation of Misfolded SOD1 in Dorsal Root Ganglion Degenerating Proprioceptive Sensory Neurons of Transgenic Mice with Amyotrophic Lateral Sclerosis

  2014cited by this paper
• Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

  2014cited by this paper
• Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.

  2014cited by this paper
• Mitochondrial Dysfunction and Decrease in Body Weight of a Transgenic Knock-in Mouse Model for TDP-43*

  2014cited by this paper
• Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration

  2014cited by this paper
• TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

  2014cited by this paper
• Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier

  2014cited by this paper
• Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

  2014cited by this paper
• The role of FUS gene variants in neurodegenerative diseases

  2014influential reference
• Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients.

  2014cited by this paper
• The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype

  2014cited by this paper
• Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations

  2014cited by this paper
• Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.

  2014cited by this paper
• Correction: Mutant TDP-43 Deregulates AMPK Activation by PP2A in ALS Models

  2014cited by this paper
• CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

  2014influential reference
• The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients

  2014cited by this paper
• MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis

  2014cited by this paper
• Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances

  2014cited by this paper
• Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

  2014cited by this paper
• Mapping amyotrophic lateral sclerosis lake risk factors across northern New England

  2014cited by this paper
• C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD

  2014cited by this paper
• Physical activity and amyotrophic lateral sclerosis: A European population‐based case–control study

  2014cited by this paper
• Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways

  2014cited by this paper

• Epigenetic Biomarkers Driven by Environmental Toxins Associated with Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the United States: A Systematic Review

  2025cites this paper
• Associations of dietary factors with amyotrophic lateral sclerosis: A Mendelian randomization study.

  2025cites this paper
• Targeting the core: C9ORF72 antagonists as pioneers in amyotrophic lateral sclerosis therapy—a computational and machine learning based approach

  2025cites this paper
• Protein Assembly Modulation: A New Approach to Amyotrophic Lateral Sclerosis (ALS) Therapeutics

  2025cites this paper
• BTEX and Aldehyde Levels in Different Residential Environments: An Exploratory Case‐Control Study in Patients With Amyotrophic Lateral Sclerosis

  2025cites this paper
• Modifications of NU-9, a potent protein aggregation inhibitor. Properties and activity in a cellular model of amyotrophic lateral sclerosis

  2025cites this paper
• Amyotrophic Lateral Sclerosis Patients Show Higher Urinary Levels of Lead and Copper: A Pilot Case-Control Study

  2025cites this paper
• Satellite glial cells: Shaping peripheral input into the brain-body axis?

  2025cites this paper
• Latest progress and challenges in drug development for degenerative motor neuron diseases

  2025cites this paper
• VGF and Its Derived Peptides in Amyotrophic Lateral Sclerosis

  2025cites this paper
• Adverse events reporting of edaravone: a real-world analysis from FAERS database

  2025cites this paper
• Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

  2024cites this paper
• Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients.

  2024cites this paper
• CD4+ T-Cell Senescence in Neurodegenerative Disease: Pathogenesis and Potential Therapeutic Targets

  2024cites this paper
• Case-control study of environmental toxins and risk of amyotrophic lateral sclerosis involving the national ALS registry

  2024cites this paper
• Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank

  2024cites this paper
• Satellite Glial Cells in Human Disease

  2024cites this paper
• Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry

  2024cites this paper
• Geographical distribution of clinical trials in amyotrophic lateral sclerosis: a scoping review

  2024cites this paper
• THE GLYMPHATIC SYSTEM AND AMYOTROPHIC LATERAL SCLEROSIS.

  2024cites this paper
• Dietary NMN supplementation enhances motor and NMJ function in ALS.

  2024cites this paper
• Skleroza amiotrofike laterale, një sëmundje e re apo tashmë e njohur edhe në Shqipëri?

  2024cites this paper
• Temporo-spatial analysis of amyotrophic lateral sclerosis in Spain: Altitude and land use as new determinants of the disease.

  2024cites this paper
• Theme 5 Human Cell Biology and Pathology

  2024cites this paper
• Unveiling the veil of adipokines: A meta-analysis and systematic review in amyotrophic lateral sclerosis.

  2024cites this paper
• Unveiling therapeutic biomarkers and druggable targets in ALS: An integrative microarray analysis, molecular docking, and structural dynamic studies

  2024cites this paper
• Potential Therapeutic Interventions Targeting NAD+ Metabolism for ALS

  2024cites this paper
• Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank

  2024cites this paper
• Microstructural Changes in the Corpus Callosum in Neurodegenerative Diseases

  2024cites this paper
• Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis

  2024cites this paper
• Are BTEX (Benzene, Toluene, Ethylbenzene and Xylenes) involved in the development of amyotrophic lateral sclerosis?

  2024cites this paper
• Amyotrophic Lateral Sclerosis and Air Pollutants in the Province of Ferrara, Northern Italy: An Ecological Study

  2023cites this paper
• Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis

  2023cites this paper
• Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy

  2023cites this paper
• Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis

  2023cites this paper
• Researches of calcium-activated chloride channel ANO1 intervening amyotrophic lateral sclerosis progression by activating EGFR and CaMKII signaling.

  2023cites this paper
• A computational biology approach to identify potential candidate protein biomarker and drug for sporadic amyotrophic lateral sclerosis.

  2023cites this paper
• Interplay of Metallome and Metabolome in Amyotrophic Lateral Sclerosis: A Study on Cerebrospinal Fluid of Patients Carrying Disease-Related Gene Mutations

  2023cites this paper
• Glycation modulates superoxide dismutase 1 aggregation and toxicity in models of sporadic amyotrophic lateral sclerosis.

  2023cites this paper
• Protein Assembly Modulation: A New Approach to ALS Therapeutics

  2023cites this paper
• ESCLEROSE LATERAL AMIOTRÓFICA (ELA): MECANISMOS, DIAGNÓSTICO E POSSÍVEIS TRATAMENTOS

  2023cites this paper
• Mendelian Randomization Analysis Reveals Statins Potentially Increase Amyotrophic Lateral Sclerosis Risk Independent of Peripheral Cholesterol-Lowering Effects

  2023cites this paper
• Risk factors of amyotrophic lateral sclerosis: a global meta-summary

  2023cites this paper
• Bile Acids Induce Neurite Outgrowth in Nsc-34 Cells via TGR5 and a Distinct Transcriptional Profile

  2023cites this paper
• Profiling TREM2 expression in amyotrophic lateral sclerosis.

  2023cites this paper
• Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis

  2022cites this paper
• Drug Discovery and Amyotrophic Lateral Sclerosis: Emerging Challenges and Therapeutic Opportunities.

  2022cites this paper
• New evidence on the association of occupation with amyotrophic lateral sclerosis: A register-based case-control study in Finland

  2022cites this paper
• Characterisation of retrotransposon insertion polymorphisms in whole genome sequencing data from individuals with amyotrophic lateral sclerosis.

  2022cites this paper
• Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study

  2022cites this paper
• Defects of Nutrient Signaling and Autophagy in Neurodegeneration

  2022influential citation
• One‐carbon metabolism pathway genes and their non‐association with the development of amyotrophic lateral sclerosis

  2022cites this paper
• A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk

  2022cites this paper
• Amyotrophic Lateral Sclerosis Pathoetiology and Pathophysiology: Roles of Astrocytes, Gut Microbiome, and Muscle Interactions via the Mitochondrial Melatonergic Pathway, with Disruption by Glyphosate-Based Herbicides

  2022cites this paper
• Emerging point‐of‐care autologous cellular therapy using adipose‐derived stromal vascular fraction for neurodegenerative diseases

  2022cites this paper
• Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update

  2021cites this paper
• No association of GSTP1 rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population

  2021influential citation
• PAK4 suppresses motor neuron degeneration in hSOD1G93A‐linked amyotrophic lateral sclerosis cell and rat models

  2021cites this paper
• S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD

  2021influential citation
• Amyotrophic Lateral Sclerosis: A Diet Review

  2021cites this paper
• Neuroprotective Effects of Testosterone in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis

  2021cites this paper
• Toxic Damage to Motor Neurons

  2021cites this paper
• Immunogenetic Epidemiology of Motor Neuron Diseases in 14 Continental Western European Countries

  2021cites this paper
• Genetic Basis of ALS

  2021cites this paper
• Glutathione S-transferase Omega 2 DD genotype is associated with an increased risk of sporadic amyotrophic lateral sclerosis in Chinese men

  2021cites this paper
• The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis

  2021influential citation
• Mitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration

  2021cites this paper
• Viral vector gene delivery of the novel chaperone protein SRCP1 to modify insoluble protein in in vitro and in vivo models of ALS

  2021influential citation
• Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis

  2021cites this paper
• Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study.

  2020cites this paper
• Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study

  2020cites this paper
• Novel neuromuscular junction model in 2D and 3D myotubes co-cultured with induced pluripotent stem cell-derived motor neurons.

  2020cites this paper
• ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage

  2020cites this paper
• Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review

  2020cites this paper
• Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study

  2020cites this paper
• A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis

  2020cites this paper
• Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis

  2020cites this paper
• Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men.

  2020cites this paper
• The role of magnetic fields in neurodegenerative diseases

  2020cites this paper
• Usefulness of diffusion tensor imaging findings as biomarkers for amyotrophic lateral sclerosis

  2020cites this paper
• Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases

  2020influential citation
• Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis

  2020cites this paper
• Curcumin and neurological diseases

  2020cites this paper
• Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge

  2020influential citation
• A de novo c.1509dupA:p.R503fs mutation of FUS: report of a girl with sporadic juvenile amyotrophic lateral sclerosis

  2020cites this paper
• A Porcine Model of Transvertebral Ultrasound and Microbubble-Mediated Blood-Spinal Cord Barrier Opening

  2020cites this paper
• Peptide variability and signatures associated with disease progression in CSF collected longitudinally from ALS patients

  2020cites this paper
• CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset.

  2020cites this paper
• Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis

  2020cites this paper
• RAB39B's role in membrane traffic, autophagy, and associated neuropathology

  2020cites this paper
• Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms

  2020cites this paper
• A Human iPSC Line Carrying a de novo Pathogenic FUS Mutation Identified in a Patient With Juvenile ALS Differentiated Into Motor Neurons With Pathological Characteristics

  2020cites this paper
• Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis

  2020cites this paper
• Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data.

  2020cites this paper
• FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS.

  2020cites this paper
• Stem Cell Transplantation for Amyotrophic Lateral Sclerosis.

  2020cites this paper
• From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis

  2020cites this paper
• Key Molecules and Pathways Underlying Sporadic Amyotrophic Lateral Sclerosis: Integrated Analysis on Gene Expression Profiles of Motor Neurons

  2020cites this paper
• Satellite Glial Cells of the Dorsal Root Ganglion: A New “Guest/Physiopathological Target” in ALS

  2020cites this paper